n | LE- Modifieda | LE- Originalb | n | UE- Modifieda | UE- originalb | |||||
---|---|---|---|---|---|---|---|---|---|---|
Median (IQR) | P-value | Median (IQR) | P-value | Median (IQR) | P-value | Median (IQR) | P-value | |||
Overallc | 172 | 69.2 (20.5) | 73.0 (21.7) | 45 | 73.1 (20.0) | 76.1 (22.3) | ||||
Age group | 0.124 | 0.04* | 0.239 | 0.492 | ||||||
Pediatric | 120 | 68.5 (20.6) | 70.7 (23.9) | 10 | 80.3 (31.7) | 81.0 (30.9) | ||||
Adult | 52 | 72.6 (19.0) | 77.0 (19.4) | 35 | 73.0 (17.3) | 76.1 (19.1) | ||||
Gender | 0.809 | 0.38 | 0.175 | 0.383 | ||||||
Male | 86 | 69.3 (22.3) | 71.8 (24.5) | 19 | 75.0 (23.8) | 81.5 (23.1) | ||||
Female | 86 | 69.1 (16.3) | 73.1 (24.5) | 26 | 72.7 (22.8) | 75.9 (29.3) | ||||
Diagnosis | 0.077 | 0.204 | 0.99 | 1 | ||||||
Osteosarcoma | 120 | 67.3 (21.2) | 71.2 (24.3) | 32 | 73.8 (19.7) | 76.5 (20.4) | ||||
Ewing sarcoma | 52 | 72.9 (15.9) | 74.6 (19.3) | 13 | 72.3 (25.8) | 76.1 (28.2) | ||||
Tumor locationd | 0.002* | 0.007* | 0.427 | 0.293 | ||||||
Tibia | 41 | 61.5 (21.7) | 65.4 (26.1) | |||||||
Femur | 112 | 70.9 (18.1) | 73.2 (20.6) | |||||||
Fibula | 17 | 73.5 (14.7) | 76.0 (13.9) | |||||||
Humerus | 27 | 70.2 (16.2) | 72.6 (26.6) | |||||||
Scapula | 11 | 74.5 (19.1) | 77.1 (22.7) | |||||||
≥ 1 year from surgery | 0.001* | < 0.001* | 0.561 | 0.819 | ||||||
No | 32 | 63.1 (27.9) | 63.0 (28.4) | 10 | 75.0 (17.3) | 72.8 (18.4) | ||||
Yes | 140 | 70.8 (19.4) | 74.1 (19.9) | 35 | 73.0 (22.0) | 76.9 (29.2) | ||||
Limb salvaged | 0.308 | 0.17 | 0.506 | 0.369 | ||||||
Prosthesis | 111 | 69.1 (19.4) | 72.9 (19.8) | 10 | 72.2 (12.4) | 74.4 (19.3) | ||||
VFG | 43 | 68.1 (24.9) | 72.2 (26.4) | 10 | 69.0 (35.7) | 74.0 (36.5) | ||||
Fibulectomy | 16 | 73.2 (12.5) | 75.5 (12.6) | |||||||
ECI | 11 | 74.5 (19.1) | 77.1 (22.7) | |||||||
Chemotherapy | 0.047* | 0.023* | 0.93 | 0.428 | ||||||
On therapye | 20 | 64.9 (24.7) | 63.6 (26.8) | 68.4 (18.0) | 69.2 (19.7) | |||||
Ended therapy | 152 | 70.2 (21.5) | 73.2 (22.6) | 73.8 (20.9) | 77.0 (23.0) |